JEFFREY J. KIMBELL & ASSOCIATES, INC.

Lobbying for BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. · Pharmaceutical company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Connecticut · House · Senate · $40,000.00 income · posted Jan 20, 2026

Lobbying activity 1

Health Issues

Issues related to diabetes and cardiovascular disease

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.